Oruka Therapeutics, Inc.

8-K Shareholder vote results Jun 4, 2026 8-K Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release); Other events Apr 30, 2026 8-K Regulation FD disclosure; Other events Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Director or officer change Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 22, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Director or officer change Jul 1, 2025 8-K Shareholder vote results Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Entered a material agreement Feb 5, 2025 8-K Entered a material agreement Dec 19, 2024 8-K Shareholder vote results Nov 18, 2024 8-K Other events Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Director or officer change Oct 4, 2024 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure Sep 13, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure Sep 5, 2024 8-K Other events Aug 27, 2024 8-K Shareholder vote results; Other events Aug 23, 2024 8-K Other events Aug 16, 2024 8-K Entered a material agreement Aug 15, 2024 8-K Results of operations (earnings release) Aug 1, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Entered a material agreement Jul 9, 2024 8-K Results of operations (earnings release) Apr 25, 2024 10-Q Quarter ended 2024-03-31 Apr 25, 2024 8-K Director or officer change Apr 23, 2024 8-K Director or officer change Apr 4, 2024 8-K Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure Apr 3, 2024 8-K Entered a material agreement Mar 22, 2024 8-K Director or officer change Feb 6, 2024 8-K Results of operations (earnings release) Feb 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 1, 2024 8-K Director or officer change; Shareholder vote results Jan 31, 2024 8-K Item 5.08 Dec 5, 2023